| Year |
Citation |
Score |
| 2023 |
Griffiths K, Greenfield JL, Halcovitch NR, Fuchter MJ, Griffin JM. Systematic Investigation into the Photoswitching and Thermal Properties of Arylazopyrazole-based MOF Host-Guest Complexes. Crystal Growth & Design. 23: 7044-7052. PMID 37808902 DOI: 10.1021/acs.cgd.2c01384 |
0.704 |
|
| 2022 |
Tyagi G, Greenfield JL, Jones BE, Sharratt WN, Khan K, Seddon D, Malone LA, Cowieson N, Evans RC, Fuchter MJ, Cabral JT. Light Responsiveness and Assembly of Arylazopyrazole-Based Surfactants in Neat and Mixed CTAB Micelles. Jacs Au. 2: 2670-2677. PMID 36590257 DOI: 10.1021/jacsau.2c00453 |
0.69 |
|
| 2022 |
Griffiths RR, Greenfield JL, Thawani AR, Jamasb AR, Moss HB, Bourached A, Jones P, McCorkindale W, Aldrick AA, Fuchter MJ, Lee AA. Data-driven discovery of molecular photoswitches with multioutput Gaussian processes. Chemical Science. 13: 13541-13551. PMID 36507171 DOI: 10.1039/d2sc04306h |
0.696 |
|
| 2022 |
Hoyas Pérez N, Sherin PS, Posligua V, Greenfield JL, Fuchter MJ, Jelfs KE, Kuimova MK, Lewis JEM. Emerging properties from mechanical tethering within a post-synthetically functionalised catenane scaffold. Chemical Science. 13: 11368-11375. PMID 36320581 DOI: 10.1039/d2sc04101d |
0.709 |
|
| 2022 |
Gonzalez A, Odaybat M, Le M, Greenfield JL, White AJP, Li X, Fuchter MJ, Han GGD. Photocontrolled Energy Storage in Azobispyrazoles with Exceptionally Large Light Penetration Depths. Journal of the American Chemical Society. 144: 19430-19436. PMID 36222796 DOI: 10.1021/jacs.2c07537 |
0.695 |
|
| 2022 |
Zhang Q, Kounde CS, Mondal M, Greenfield JL, Baker JR, Kotelnikov S, Ignatov M, Tinworth CP, Zhang L, Conole D, De Vita E, Kozakov D, McCluskey A, Harling JD, Fuchter MJ, et al. Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs). Chemical Communications (Cambridge, England). PMID 36065962 DOI: 10.1039/d2cc03092f |
0.698 |
|
| 2021 |
Greenfield JL, Gerkman MA, Gibson RSL, Han GGD, Fuchter MJ. Efficient Electrocatalytic Switching of Azoheteroarenes in the Condensed Phases. Journal of the American Chemical Society. PMID 34519491 DOI: 10.1021/jacs.1c06359 |
0.695 |
|
| 2021 |
Greenfield JL, Wade J, Brandt JR, Shi X, Penfold TJ, Fuchter MJ. Pathways to increase the dissymmetry in the interaction of chiral light and chiral molecules. Chemical Science. 12: 8589-8602. PMID 34257860 DOI: 10.1039/d1sc02335g |
0.702 |
|
| 2021 |
Lanyon-Hogg T, Ritzefeld M, Zhang L, Pogranyi B, Mondal M, Sefer L, Johnston CD, Coupland CE, Andrei SA, Newington J, Magee AI, Siebold C, Tate EW, Fuchter MJ, Greenfield JL. Photochemical probe identification of a small-molecule inhibitor binding site in Hedgehog acyltransferase (HHAT). Angewandte Chemie (International Ed. in English). PMID 33768725 DOI: 10.1002/anie.202014457 |
0.711 |
|
| 2020 |
Rushworth JL, Montgomery KS, Cao B, Brown R, Dibb NJ, Nilsson SK, Chiefari J, Fuchter MJ. Glycosylated Nanoparticles Derived from RAFT Polymerization for Effective Drug Delivery to Macrophages. Acs Applied Bio Materials. 3: 5775-5786. PMID 35021808 DOI: 10.1021/acsabm.0c00529 |
0.755 |
|
| 2020 |
Fuchter MJ. On the Promise of Photopharmacology Using Photoswitches: A Medicinal Chemist's Perspective. Journal of Medicinal Chemistry. PMID 32511922 DOI: 10.1021/Acs.Jmedchem.0C00629 |
0.319 |
|
| 2019 |
Calbo J, Thawani AR, Gibson RSL, White AJP, Fuchter MJ. A combinatorial approach to improving the performance of azoarene photoswitches. Beilstein Journal of Organic Chemistry. 15: 2753-2764. PMID 31807208 DOI: 10.3762/Bjoc.15.266 |
0.311 |
|
| 2019 |
Rueda-Zubiaurre A, Yahiya S, Fischer O, Hu X, Saunders C, Sharma S, Straschil U, Shen J, Tate EW, Delves M, Baum J, Barnard A, Fuchter MJ. Structure-activity relationship studies of a novel class of transmission blocking antimalarials targeting male gametes. Journal of Medicinal Chemistry. PMID 31490680 DOI: 10.1021/Acs.Jmedchem.9B00898 |
0.31 |
|
| 2018 |
Delves MJ, Miguel-Blanco C, Matthews H, Molina I, Ruecker A, Yahiya S, Straschil U, Abraham M, León ML, Fischer OJ, Rueda-Zubiaurre A, Brandt JR, Cortés Á, Barnard A, Fuchter MJ, et al. A high throughput screen for next-generation leads targeting malaria parasite transmission. Nature Communications. 9: 3805. PMID 30228275 DOI: 10.1038/S41467-018-05777-2 |
0.305 |
|
| 2018 |
Chavas TEJ, Fuchter MJ, DiMaggio PA. Unbiased Mass Spectrometry Elucidation of the Targets and Mechanisms of Activity-Based Probes: A Case Study involving Sulfonyl Fluorides. Acs Chemical Biology. PMID 30192509 DOI: 10.1021/Acschembio.8B00530 |
0.311 |
|
| 2018 |
Patel H, Periyasamy M, Sava GP, Bondke A, Slafer BW, Kroll SHB, Barbazanges M, Starkey R, Ottaviani S, Harrod A, Aboagye EO, Buluwela L, Fuchter MJ, Barrett AGM, Coombes C, et al. ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. Molecular Cancer Therapeutics. PMID 29545334 DOI: 10.1158/1535-7163.Mct-16-0847 |
0.32 |
|
| 2018 |
Lubin AS, Zubiaurre AR, Matthews H, Baumann H, Fisher FR, Morales-Sanfrutos J, Hadavizadeh KS, Nardella F, Tate EW, Baum J, Scherf A, Fuchter MJ. Development of a Photo-crosslinkable Diaminoquinazoline Inhibitor for Target Identification in Plasmodium Falciparum. Acs Infectious Diseases. PMID 29377668 DOI: 10.1021/Acsinfecdis.7B00228 |
0.334 |
|
| 2018 |
Hazel P, Kroll SHB, Bondke A, Barbazanges M, Patel H, Fuchter MJ, Coombes RC, Ali S, Barrett AGM, Freemont PS. Corrigendum: Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling Study. Chemmedchem. 13: 207. PMID 29372749 DOI: 10.1002/Cmdc.201700826 |
0.318 |
|
| 2018 |
Ali S, Patel H, Periyasamy M, Sava G, Bondke A, Slafer B, Kroll S, Barbazanges M, Starkey R, Ottaviani S, Harrod A, Aboagye E, Buluwela L, Fuchter M, Barrett A, et al. Abstract P1-10-05: ICEC0942, a new oral selective inhibitor of the cell cycle and transcriptional regulator CDK7 for the treatment of estrogen receptor positive and negative breast cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P1-10-05 |
0.324 |
|
| 2018 |
Montgomery KS, Davidson RWM, Cao B, Williams B, Simpson GW, Nilsson SK, Chiefari J, Fuchter MJ. Effective macrophage delivery using RAFT copolymer derived nanoparticles Polymer Chemistry. 9: 131-137. DOI: 10.1039/C7Py01363A |
0.301 |
|
| 2017 |
Sundriyal S, Chen PB, Lubin AS, Lueg GA, Li F, White AJP, Malmquist NA, Vedadi M, Scherf A, Fuchter MJ. Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity. Medchemcomm. 8: 1069-1092. PMID 29308121 DOI: 10.1039/C7Md00052A |
0.36 |
|
| 2017 |
Sundriyal S, Moniot S, Mahmud Z, Yao S, Di Fruscia P, Reynolds CR, Dexter DT, Sternberg MJ, Lam EW, Steegborn C, Fuchter MJ. Thienopyrimidinone based sirtuin-2 (SIRT2)-selective inhibitors bind in the ligand induced 'selectivity pocket'. Journal of Medicinal Chemistry. PMID 28135086 DOI: 10.1021/Acs.Jmedchem.6B01690 |
0.37 |
|
| 2017 |
Hazel P, Kroll SH, Bondke A, Barbazanges M, Patel H, Fuchter MJ, Coombes RC, Ali S, Barrett AG, Freemont P. Inhibitor selectivity for CDK7 - a structural, thermodynamic and modelling study. Chemmedchem. PMID 28125165 DOI: 10.1002/Cmdc.201600535 |
0.723 |
|
| 2016 |
Calbo J, Weston CE, White A, Rzepa H, Contreras-García J, Fuchter MJ. Tuning Azoheteroarene Photoswitch Performance through Heteroaryl Design. Journal of the American Chemical Society. PMID 28009517 DOI: 10.1021/Jacs.6B11626 |
0.31 |
|
| 2016 |
Weston CE, Kraemer A, Colin F, Yildiz Ö, Baud MG, Meyer-Almes FJ, Fuchter MJ. Towards photopharmacological antimicrobial chemotherapy using photoswitchable amidohydrolase inhibitors. Acs Infectious Diseases. PMID 27756124 DOI: 10.1021/Acsinfecdis.6B00148 |
0.365 |
|
| 2016 |
Chen PB, Ding S, Zanghì G, Soulard V, DiMaggio PA, Fuchter MJ, Mecheri S, Mazier D, Scherf A, Malmquist NA. Plasmodium falciparum PfSET7: enzymatic characterization and cellular localization of a novel protein methyltransferase in sporozoite, liver and erythrocytic stage parasites. Scientific Reports. 6: 21802. PMID 26902486 DOI: 10.1038/Srep21802 |
0.312 |
|
| 2015 |
Richardson RD, Baud MGJ, Weston CE, Rzepa HS, Kuimova MK, Fuchter MJ. Dual wavelength asymmetric photochemical synthesis with circularly polarized light. Chemical Science. 6: 3853-3862. PMID 29218156 DOI: 10.1039/C4Sc03897E |
0.304 |
|
| 2015 |
Curry E, Green I, Chapman-Rothe N, Shamsaei E, Kandil S, Cherblanc FL, Payne L, Bell E, Ganesh T, Srimongkolpithak N, Caron J, Li F, Uren AG, Snyder JP, Vedadi M, ... Fuchter MJ, et al. Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells. Clinical Epigenetics. 7: 84. PMID 26300989 DOI: 10.1016/S0959-8049(14)70680-X |
0.753 |
|
| 2015 |
Malmquist NA, Sundriyal S, Caron J, Chen P, Witkowski B, Menard D, Suwanarusk R, Renia L, Nosten F, Jiménez-Díaz MB, Angulo-Barturen I, Santos Martínez M, Ferrer S, Sanz LM, Gamo FJ, ... ... Fuchter MJ, et al. Histone methyltransferase inhibitors are orally bioavailable, fast-acting molecules with activity against different species causing malaria in humans. Antimicrobial Agents and Chemotherapy. 59: 950-9. PMID 25421480 DOI: 10.1128/Aac.04419-14 |
0.336 |
|
| 2015 |
Di Fruscia P, Zacharioudakis E, Liu C, Moniot S, Laohasinnarong S, Khongkow M, Harrison IF, Koltsida K, Reynolds CR, Schmidtkunz K, Jung M, Chapman KL, Steegborn C, Dexter DT, Sternberg MJ, ... ... Fuchter MJ, et al. The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model. Chemmedchem. 10: 69-82. PMID 25395356 DOI: 10.1002/Cmdc.201402431 |
0.354 |
|
| 2014 |
Srimongkolpithak N, Sundriyal S, Li F, Vedadi M, Fuchter MJ. Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors†Electronic supplementary information (ESI) available. See DOI: 10.1039/c4md00274a. Medchemcomm. 5: 1821-1828. PMID 25750706 DOI: 10.1039/C4Md00274A |
0.762 |
|
| 2014 |
Sundriyal S, Malmquist NA, Caron J, Blundell S, Liu F, Chen X, Srimongkolpithak N, Jin J, Charman SA, Scherf A, Fuchter MJ. Development of diaminoquinazoline histone lysine methyltransferase inhibitors as potent blood-stage antimalarial compounds. Chemmedchem. 9: 2360-73. PMID 25044750 DOI: 10.1002/Cmdc.201402098 |
0.776 |
|
| 2014 |
Meyners C, Baud MG, Fuchter MJ, Meyer-Almes FJ. Kinetic method for the large-scale analysis of the binding mechanism of histone deacetylase inhibitors. Analytical Biochemistry. 460: 39-46. PMID 24882269 DOI: 10.1016/J.Ab.2014.05.014 |
0.342 |
|
| 2014 |
Dembélé L, Franetich JF, Lorthiois A, Gego A, Zeeman AM, Kocken CH, Le Grand R, Dereuddre-Bosquet N, van Gemert GJ, Sauerwein R, Vaillant JC, Hannoun L, Fuchter MJ, Diagana TT, Malmquist NA, et al. Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures. Nature Medicine. 20: 307-12. PMID 24509527 DOI: 10.1038/Nm.3461 |
0.304 |
|
| 2014 |
Meyners C, Baud MG, Fuchter MJ, Meyer-Almes FJ. Thermodynamics of ligand binding to histone deacetylase like amidohydrolase from Bordetella/Alcaligenes. Journal of Molecular Recognition : Jmr. 27: 160-72. PMID 24446380 DOI: 10.1002/Jmr.2345 |
0.337 |
|
| 2013 |
Cherblanc FL, Chapman KL, Reid J, Borg AJ, Sundriyal S, Alcazar-Fuoli L, Bignell E, Demetriades M, Schofield CJ, DiMaggio PA, Brown R, Fuchter MJ. On the histone lysine methyltransferase activity of fungal metabolite chaetocin. Journal of Medicinal Chemistry. 56: 8616-25. PMID 24099080 DOI: 10.1021/Jm401063R |
0.379 |
|
| 2013 |
Kaliszczak M, Patel H, Kroll SH, Carroll L, Smith G, Delaney S, Heathcote DA, Bondke A, Fuchter MJ, Coombes RC, Barrett AG, Ali S, Aboagye EO. Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance. British Journal of Cancer. 109: 2356-67. PMID 24071597 DOI: 10.1038/Bjc.2013.584 |
0.712 |
|
| 2013 |
Weimar M, Correa da Costa R, Lee FH, Fuchter MJ. A scalable and expedient route to 1-aza[6]helicene derivatives and its subsequent application to a chiral-relay asymmetric strategy. Organic Letters. 15: 1706-9. PMID 23517238 DOI: 10.1021/Ol400493X |
0.306 |
|
| 2013 |
Cherblanc FL, Chapman KL, Brown R, Fuchter MJ. Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases. Nature Chemical Biology. 9: 136-7. PMID 23416387 DOI: 10.1038/Nchembio.1187 |
0.318 |
|
| 2013 |
Baud MG, Leiser T, Petrucci V, Gunaratnam M, Neidle S, Meyer-Almes FJ, Fuchter MJ. Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors. Beilstein Journal of Organic Chemistry. 9: 81-8. PMID 23400330 DOI: 10.3762/Bjoc.9.11 |
0.383 |
|
| 2013 |
Cherblanc FL, Davidson RW, Di Fruscia P, Srimongkolpithak N, Fuchter MJ. Perspectives on natural product epigenetic modulators in chemical biology and medicine. Natural Product Reports. 30: 605-24. PMID 23396528 DOI: 10.1039/C3Np20097C |
0.762 |
|
| 2013 |
Baud MG, Haus P, Leiser T, Meyer-Almes FJ, Fuchter MJ. Highly ligand efficient and selective N-2-(Thioethyl)picolinamide histone deacetylase inhibitors inspired by the natural product psammaplin A. Chemmedchem. 8: 149-56. PMID 23184734 DOI: 10.1002/Cmdc.201200450 |
0.386 |
|
| 2013 |
Ottaviani S, Delaney S, Patel H, Periyasamy M, Bondke A, Slafer B, Starkey R, Kroll SHB, Fuchter MJ, Barrett AGM, Coombes RC, Ali S. Abstract 700: Gene expression profiling of cyclin-dependent kinase (CDK) inhibition in cancer cells. Cancer Research. 73: 700-700. DOI: 10.1158/1538-7445.Am2013-700 |
0.329 |
|
| 2013 |
Patel H, Ottaviani S, Periyasamy M, Bondke A, Slafer B, Starkey R, Kroll SHB, Delaney S, Zahoor Z, Fuchter MJ, Barrett AGM, Coombes RC, Ali S. Abstract 694: Development of selective and potent CDK7 inhibitors for breast cancer therapy. Cancer Research. 73: 694-694. DOI: 10.1158/1538-7445.Am2013-694 |
0.35 |
|
| 2012 |
Di Fruscia P, Ho KK, Laohasinnarong S, Khongkow M, Kroll SH, Islam SA, Sternberg MJ, Schmidtkunz K, Jung M, Lam EW, Fuchter MJ. The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors. Medchemcomm. PMID 24340169 DOI: 10.1039/C2Md00290F |
0.366 |
|
| 2012 |
Malmquist NA, Moss TA, Mecheri S, Scherf A, Fuchter MJ. Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America. 109: 16708-13. PMID 23011794 DOI: 10.1073/Pnas.1205414109 |
0.344 |
|
| 2012 |
Cherblanc F, Chapman-Rothe N, Brown R, Fuchter M. Current limitations and future opportunities for epigenetic therapies Future Medicinal Chemistry. 4: 425-446. PMID 22416773 DOI: 10.4155/Fmc.12.7 |
0.323 |
|
| 2012 |
Baud MGJ, Leiser T, Haus P, Samlal S, Wong AC, Wood RJ, Petrucci V, Gunaratnam M, Hughes SM, Buluwela L, Turlais F, Neidle S, Meyer-Almes FJ, White AJP, Fuchter MJ. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets Journal of Medicinal Chemistry. 55: 1731-1750. PMID 22280363 DOI: 10.1021/Jm2016182 |
0.387 |
|
| 2011 |
Baud MG, Leiser T, Meyer-Almes FJ, Fuchter MJ. New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation. Organic & Biomolecular Chemistry. 9: 659-62. PMID 21113514 DOI: 10.1039/C0Ob00824A |
0.38 |
|
| 2011 |
Fuchter MJ, Baud MGJ, Leiser T, Samlal S, Wong AC, Wood RJ, Gunaratnam M, Hughes SM, Buluwela L, Turlais F, Neidle S, Meyer-Almes F. Abstract B166: Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B166 |
0.392 |
|
| 2011 |
Cherblanc FL, Lo Y, Bignell EM, Alcazar-Fuoli L, Brown R, Chapman-Rothe N, Rzepa HS, Fuchter MJ. Abstract B165: Structural and biological studies on analogues of the natural product histone methyltransferase inhibitor chaetocin. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-B165 |
0.393 |
|
| 2011 |
Chapman-Rothe N, Shamsaei E, Cherblanc F, Ganesh T, Snyder JP, Fuchter MJ, Brown R. Abstract A162: Targeting chromatin: Small molecules reactivating H3K27me3 silenced genes. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A162 |
0.36 |
|
| 2010 |
Heathcote DA, Patel H, Kroll SH, Hazel P, Periyasamy M, Alikian M, Kanneganti SK, Jogalekar AS, Scheiper B, Barbazanges M, Blum A, Brackow J, Siwicka A, Pace RD, Fuchter MJ, et al. A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration. Journal of Medicinal Chemistry. 53: 8508-22. PMID 21080703 DOI: 10.1021/Jm100732T |
0.718 |
|
| 2010 |
Peck B, Chen CY, Ho KK, Di Fruscia P, Myatt SS, Coombes RC, Fuchter MJ, Hsiao CD, Lam EW. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Molecular Cancer Therapeutics. 9: 844-55. PMID 20371709 DOI: 10.1158/1535-7163.Mct-09-0971 |
0.322 |
|
| 2010 |
Saubern S, Macdonald JM, Ryan JH, Woodgate RCJ, Louie TS, Fuchter MJ, White JM, Holmes AB. Tricyclic-isoxazolidine analogues via intramolecular 1,3-dipolar cycloaddition reactions of nitrones Tetrahedron. 66: 2761-2767. DOI: 10.1016/J.Tet.2010.01.062 |
0.426 |
|
| 2009 |
Ali S, Heathcote DA, Kroll SH, Jogalekar AS, Scheiper B, Patel H, Brackow J, Siwicka A, Fuchter MJ, Periyasamy M, Tolhurst RS, Kanneganti SK, Snyder JP, Liotta DC, Aboagye EO, et al. The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Research. 69: 6208-15. PMID 19638587 DOI: 10.1158/0008-5472.Can-09-0301 |
0.721 |
|
| 2009 |
Goslinski T, Zhong C, Fuchter MJ, White AJP, Barrett AGM, Hoffman BM. Serendipitous synthesis of trimetallic porphyrazine triads Tetrahedron Letters. 50: 5178-5181. DOI: 10.1016/J.Tetlet.2009.06.120 |
0.307 |
|
| 2008 |
Lee JK, Fuchter MJ, Williamson RM, Leeke GA, Bush EJ, McConvey IF, Saubern S, Ryan JH, Holmes AB. Diaryl ether synthesis in supercritical carbon dioxide in batch and continuous flow modes. Chemical Communications (Cambridge, England). 4780-2. PMID 18830491 DOI: 10.1039/B808374F |
0.423 |
|
| 2008 |
Fuchter MJ, Smith CJ, Tsang MW, Boyer A, Saubern S, Ryan JH, Holmes AB. Clean and efficient synthesis of O-silylcarbamates and ureas in supercritical carbon dioxide. Chemical Communications (Cambridge, England). 2152-4. PMID 18438499 DOI: 10.1039/B801537F |
0.405 |
|
| 2008 |
Fuchter MJ, Zhong C, Zong H, Hoffman BM, Barrett AGM. Porphyrazines: Designer macrocycles by peripheral substituent change Australian Journal of Chemistry. 61: 235-255. DOI: 10.1071/Ch07445 |
0.328 |
|
| 2007 |
Guinchard X, Fuchter MJ, Ruggiero A, Duckworth BJ, Barrett AG, Hoffman BM. Multigram synthesis of a water-soluble porphyrazine and derived seco-porphyrazine labeling agents. Organic Letters. 9: 5291-4. PMID 18001047 DOI: 10.1021/Ol702481X |
0.684 |
|
| 2006 |
Goslinski T, Zhong C, Fuchter MJ, Stern CL, White AJ, Barrett AG, Hoffman BM. Porphyrazines as molecular scaffolds: flexible syntheses of novel multimetallic complexes. Inorganic Chemistry. 45: 3686-94. PMID 16634602 DOI: 10.1021/Ic060176N |
0.693 |
|
| 2006 |
Fuchter MJ, Hoffman BM, Barrett AG. Ring-opening metathesis polymer sphere-supported seco-porphyrazines: efficient and recyclable photooxygenation catalysts. The Journal of Organic Chemistry. 71: 724-9. PMID 16408985 DOI: 10.1021/Jo052156T |
0.697 |
|
| 2005 |
Fuchter MJ, Hoffman BM, Barrett AG. ROM polymerization-capture-release: application to the synthesis of unsymmetrical porphyrazinedithiols and peripherally metalated derivatives. The Journal of Organic Chemistry. 70: 5086-91. PMID 15960508 DOI: 10.1021/Jo050369C |
0.706 |
|
| 2005 |
Fuchter MJ, Vesper BJ, Murphy KA, Collins HA, Phillips D, Barrett AG, Hoffman BM. ROM polymerization-capture-release strategy for the chromatography-free synthesis of novel unsymmetrical porphyrazines. The Journal of Organic Chemistry. 70: 2793-802. PMID 15787573 DOI: 10.1021/Jo047792Q |
0.71 |
|
| 2005 |
Fuchter MJ, Beall LS, Baum SM, Montalban AG, Sakellariou EG, Mani NS, Miller T, Vesper BJ, White AJP, Williams DJ, Barrett AGM, Hoffman BM. Synthesis of porphyrazine-octaamine, hexamine and diamine derivatives Tetrahedron. 61: 6115-6130. DOI: 10.1016/J.Tet.2005.03.090 |
0.322 |
|
| Show low-probability matches. |